Drugs / TBC3711
last change Aug 2008 re-read 3 minutes ago

TBC3711

Developed for
resistant hypertension
Investigated by
Pfizer

Trials 1

2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00272961 Jan 2006 → Aug 2008 resistant hypertension Pfizer Terminated Mixed

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as TBC3711 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00272961 ↗